Control of insulin receptor autophosphorylation by polypeptide substrates: inhibition and stimulation by interaction

R A Kohanski1, E Schenker

  • 1Department of Biochemistry, Mount Sinai School of Medicine, New York, New York 10029.

Biochemistry
|March 5, 1991
PubMed

Insights

Selected peptides can stimulate insulin receptor autophosphorylation, acting on the beta-subunit. This peptide stimulation mimics insulin

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • The insulin receptor plays a crucial role in glucose metabolism and cellular signaling.
  • Autophosphorylation is a key regulatory step in insulin receptor activation.
  • Understanding the mechanisms of insulin receptor activation is vital for metabolic research.

Purpose of the Study:

  • To investigate the effect of specific polypeptide substrates on insulin receptor autophosphorylation.
  • To elucidate the mechanism by which peptides stimulate or inhibit receptor activity.
  • To compare peptide-mediated stimulation with insulin-mediated activation.

Main Methods:

  • Purification of the insulin receptor.
  • Assaying autophosphorylation in the presence and absence of insulin and various peptide substrates.
  • Utilizing modified lysozyme peptides and angiotensin as substrates.
  • Analyzing autophosphorylation of the cloned cytoplasmic domain of the kinase (R-BIRK).
  • Mapping 32P-labeled tryptic phosphopeptides.

Main Results:

  • Certain polypeptide substrates stimulated insulin receptor autophosphorylation independently of insulin.
  • These peptides inhibited autophosphorylation in the presence of insulin.
  • Peptide stimulation primarily involved the cytoplasmic beta-subunit, not the alpha-subunit.
  • Peptide-stimulated R-BIRK showed similar phosphopeptide maps to insulin-stimulated native receptor.
  • Peptide stimulation resulted in similar functional outcomes to insulin but via distinct mechanisms.

Conclusions:

  • Polypeptide substrates can modulate insulin receptor activity through interaction with the cytoplasmic domain.
  • Peptide-mediated stimulation of the insulin receptor kinase domain mimics insulin's effects.
  • Distinct mechanisms underlie peptide and insulin stimulation, despite similar functional outcomes.
  • The cloned cytoplasmic domain (R-BIRK) serves as a valuable model for studying receptor activation.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K